Cardiac Omnibus Codes - (0574) — MM 0574 | CIGNA Coverage Update

TL;DR: Cigna Healthcare modified MM 0574, its cardiac omnibus coverage policy, effective February 14, 2026. Every cardiac device and procedure covered under this policy — spanning CPT codes 0266T through 0981T and HCPCS codes C1824, C1825, C2624, and G0555 — carries an Experimental/Investigational/Unproven designation. Here's what billing teams need to know.

Cigna Healthcare updated MM 0574, the Cigna cardiac omnibus coverage policy, on February 14, 2026. This policy governs a broad set of advanced cardiac devices — including baroreflex activation therapy, cardiac contractility modulation systems, and wireless hemodynamic pressure sensors. If your practice or facility bills any of these services to Cigna, expect denials. Every code in this policy sits in the Experimental/Investigational/Unproven bucket.

Quick-Reference Table

Cigna Cardiac Device Coverage Criteria and Medical Necessity Requirements 2026

The core position in the MM 0574 Cigna cardiac omnibus coverage policy is straightforward: Cigna classifies all devices and procedures under MM 0574 as Experimental/Investigational/Unproven. The policy provides no covered indications. That applies across the board — baroreflex activation, cardiac contractility modulation, left atrial pressure sensors, pulmonary artery pressure sensors, and inferior vena cava sensors.

That classification matters for your billing team because it triggers automatic claim denial regardless of diagnosis, patient severity, or physician documentation. There is no clinical pathway that unlocks coverage under this policy. You cannot overcome an Experimental/Investigational designation with a stronger prior authorization request or more detailed chart notes.

The source data does not describe what changed from the prior version. Review the full policy diff for version comparison.

The source policy does not address prior authorization. Consult your Cigna provider agreement for applicable PA requirements. Document that process internally, and redirect administrative time accordingly.

For billing purposes, the policy is the policy. Reimbursement under Cigna for these services is not available under MM 0574.

Cigna Cardiac Omnibus Exclusions and Non-Covered Indications

Every device and procedure in MM 0574 carries the same designation: Experimental/Investigational/Unproven. There are no covered indications, no coverage tiers, and no exceptions listed in this policy.

The devices addressed include:

The breadth of codes here is the real issue. It's not just the implantation codes — the associated catheterization, fluoroscopy, hemodynamic assessment, and pressure measurement codes (the 93xxx series and the 36xxx/75xxx series) are also swept in. If you bill a hemodynamic study in conjunction with a pulmonary artery pressure sensor implant, the companion codes go down with it.

Coverage Indications at a Glance

Cigna Cardiac Omnibus Billing Guidelines and Action Items 2026

The billing implications here are direct. These aren't gray-area codes where documentation might tip a denial to an approval. Every code in MM 0574 is categorically excluded. Your action items should focus on protection — stopping write-offs, managing patient financial counseling, and documenting the denial rationale for appeals or alternative payer pursuit.

CPT, HCPCS, and ICD-10 Codes for Cardiac Omnibus Devices Under MM 0574

No covered CPT or HCPCS codes exist under this policy. All codes below carry the Experimental/Investigational/Unproven classification. No ICD-10 codes are specified in the MM 0574 policy data.

Not Covered / Experimental CPT Codes

Not Covered / Experimental HCPCS Codes